Insider tied to AEHR (NASDAQ: AEHR) files to sell 503 shares

Rhea-AI Filing Summary

A holder of AEHR common stock has filed a notice of intended share sales under SEC Rule 144. The filing covers a planned sale of 503 common shares through The Charles Schwab Corporation on NASDAQ, with an aggregate market value of $13,440.16 as of the filing details.

The securities were originally acquired on 10/19/2022 as equity compensation from the issuer. The filing also notes that Laura A. Oliphant sold 4,546 common shares on 01/22/2026 for gross proceeds of $142,750.68, reflecting recent selling activity related to the same issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	The Charles Schwab Corporation 3000 Schwab Way Westlake TX 76262	503	13440.16	30627342	01/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/19/2022	Equity Compensation	Issuer			503	10/19/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Laura A Oliphant 400 Kato Terrace Fremont CA 94539	Common	01/22/2026	4546	142750.68

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AEHR’s latest Form 144 filing disclose?

The Form 144 filing discloses an intended sale of 503 AEHR common shares through The Charles Schwab Corporation on NASDAQ, with an aggregate market value of $13,440.16. It also references a prior sale of 4,546 shares on January 22, 2026.

How many AEHR shares are covered by the new Rule 144 sale notice?

The notice covers an intended sale of 503 AEHR common shares. These shares are to be sold through The Charles Schwab Corporation on NASDAQ, with the filing showing an aggregate market value of $13,440.16 for this proposed transaction.

How were the AEHR shares in the Form 144 originally acquired?

The 503 AEHR common shares in the Form 144 were acquired on October 19, 2022 as equity compensation from the issuer. The same date is listed for both acquisition and payment, and the nature of payment is shown as not applicable.

What recent AEHR share sales by Laura A. Oliphant are disclosed?

The filing reports that Laura A. Oliphant sold 4,546 AEHR common shares on January 22, 2026. These sales generated gross proceeds of $142,750.68 and are listed as securities of the same issuer sold during the past three months.

On which exchange are the AEHR shares in the Form 144 expected to be sold?

The AEHR common shares referenced in the Form 144 are expected to be sold on NASDAQ. The filing lists NASDAQ as the securities exchange, with The Charles Schwab Corporation serving as the broker handling the planned 503-share sale.